Wells Fargo raised the firm’s price target on Tenet Healthcare to $175 from $145 and keeps an Overweight rating on the shares. The firm notes Hospital results and guides in Q2 generally exceeded expectations. Wells cites higher estimates and rolling forward for the price target raise. The firm expects the second half of 2024 fundamentals to remain fairly strong but 2025/2026 seems likely to be more normalized.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Tenet Healthcare price target raised to $171 from $156 at Barclays
- Tenet Healthcare price target raised to $170 from $155 at Truist
- Tenet Healthcare price target raised to $175 from $130 at Raymond James
- Tenet Healthcare price target raised to $160 from $155 at Deutsche Bank
- Tenet Healthcare price target raised to $168 from $112 at Cantor Fitzgerald
